Biocurrent, Inc.

biocurrent, inc. is an early stage bioelectronic medicine company with a clear path to sustainable revenue. the company's research into non-invasive neuromodulation led to the development of an advanced prototype device, database, and machine learning engine. their invention delivers dynamically generated, modulated electrical current varying in frequency, intensity, timing and, waveform. the current flow is optimized by real-time brain wave spikes and discharges received wirelessly from an electroencephalogram (eeg). based on preclinical studies, the company's technology may be effective at treating a wide range of neurological disorders and disabilities including pain, addiction, and cancer. their business model provides sustainable revenue to both the company and treatment providers. biocurrent is now seeking funding for clinical trials, industrialization, and commercialization.